Comparison
HMB (β-Hydroxy-β-Methylbutyrate) vs. Leucine
HMB or leucine – what really works for muscle growth and strength?
The short answer
Leucine is the trigger, HMB its breakdown product – and what is proven differs for each. Leucine demonstrably switches on muscle protein synthesis in humans via mTORC1; in a tracer study it rose by 110%, and the signalling cascade stayed active longer than after HMB. HMB shows small strength gains in training beginners and small effects in patients with muscle wasting. Where the data end: isolated leucine gave older adults neither muscle mass nor strength over months; measurable effects come mainly from combinations with protein and vitamin D. HMB gave trained people and older adults doing resistance training no additional benefit. There is no study directly comparing the two on muscle mass or strength, and long-term safety data are missing for both.
The numbers side by side
| Axis | HMB (β-Hydroxy-β-Methylbutyrate) | Leucine | Difference |
|---|---|---|---|
| Human evidenceHow much and how good the data in humans are | 7 | 6 | HMB better studied |
| MechanismHow well the chain of action is understood | 6 | 8 | Leucine better studied |
| Safety dataHow well safety has been studied – not how safe it is | 6 | 6 | even |
| Hype gap10 means: the advertising stays level with the data | 4 | 5 | Leucine closer to the data |
| Track record of useHow much documented use in humans exists – does not measure whether it works | 7 | 6 | HMB in use longer |
| Rating | Supported, with caveats · Supported, with caveats | ||
“Track record of use” measures how long and how widely something has been used in humans – not whether it works. The BK-Score is a subjective assessment by Biohacking Kompakt based on published scoring rules (German). It is not a scientific rating, not the consensus of a professional society and not a medical recommendation.
Why these numbers
HMB (β-Hydroxy-β-Methylbutyrate)
Evidence 7, because numerous RCTs and several meta-analyses exist that diverge by group: no effect in trained individuals (Sanchez-Martinez 2018, 6 RCTs with 193 athletes) and in young adults doing resistance training (Jakubowski 2020, 11 studies), small strength gains in untrained individuals (Rowlands 2009) and small effects in patients with muscle wasting (Bear 2019, 15 RCTs with 2,137 patients), no additional benefit in older adults doing resistance training (Wang 2026, 13 RCTs). Mechanism 6, because HMB, as a leucine metabolite, plausibly intervenes in protein synthesis and breakdown, but in trained individuals with adequate protein intake this does not translate into muscle mass. Safety 6, because an analysis of 9 studies with 3 g per day over 3 to 8 weeks found no adverse blood or organ values (Nissen 2000), but long-term data and an official maximum level are lacking. Hype 4, because HMB is advertised as a muscle builder for athletes yet shows no effect precisely there, and the spectacular Wilson results (7.4 kg lean mass in 12 weeks) were criticised for inconsistencies and never independently confirmed. Application 7, because HMB has been widely used for many years in sports nutrition and clinical oral nutritional supplements. Mixed direction: no benefit in trained individuals, small effects in untrained individuals and patients.
Leucine
Evidence 6, because numerous RCTs and several meta-analyses exist, but they diverge: isolated leucine changed neither fat-free mass nor strength in older adults (Guo 2022, 17 RCTs with 1,418 participants; Verhoeven 2009, 7.5 g per day over 3 months), whereas leucine-rich combination products improved strength in sarcopenia (Lee 2022, 6 RCTs; PROVIDE with 380 participants only on secondary endpoints). Mechanism 8, because activation of muscle protein synthesis via mTORC1 has been quantified in humans with tracer studies (+110% with 3.42 g, Wilkinson 2013; meta-analysis of 9 RCTs, Xu 2015), but the step from synthesis rate to muscle mass does not succeed. Safety 6, because controlled data over 3 months are unremarkable and acute studies show ammonia increases only at very high amounts, but the BfR had to derive its guidance values (4.0 g leucine per day) from animal studies for lack of human data. Hype 5, because leucine is advertised as a muscle builder although only acute synthesis is proven and isolated leucine does not build muscle over months. Application 6, because leucine has been widely used for many years in sports nutrition and clinical oral nutritional supplements and is classified in Germany via a BVL general ruling and BfR guidance values. Mixed direction: clear mechanism and positive combination data, but no effect of leucine alone on muscle mass and strength.
Frequently asked questions
Is HMB better than leucine?
It depends on what is measured; there is no study directly comparing the two on muscle mass or strength. For the acute muscle-building signal, leucine is stronger: in tracer studies it increases synthesis more, while HMB additionally slows muscle breakdown. Over months, isolated leucine shows no effect on muscle mass and strength, HMB small effects in untrained people and patients. In the BK-Score, human evidence is 7 for HMB and 6 for leucine, mechanism 6 versus 8.
Do HMB or leucine give trained people more muscle?
For HMB, the meta-analyses say no: in 193 trained athletes across 6 randomised trials, strength, lean mass and fat mass did not change, and in young adults doing resistance training only body weight rose slightly across 11 studies. The spectacular Wilson results are disputed and unconfirmed. For leucine it is proven that, after resistance training, it makes a small protein serving act on muscle protein synthesis almost as strongly as a large one in the short term; studies with isolated leucine show no extra muscle over months.
What helps older people against muscle loss: HMB or leucine?
The best data are for combinations, not single substances. Leucine-rich protein and vitamin D products improved strength in sarcopenia, in one larger analysis handgrip strength by 2.17 kg; isolated leucine over three months, by contrast, changed neither muscle mass nor strength. HMB showed small effects in patients with muscle wasting across 15 RCTs, but many products contained other nutrients as well. People aged 50 and over doing resistance training gained nothing extra with HMB across 13 RCTs.
How safe are HMB and leucine?
Unremarkable in the short term. For HMB, an analysis of 9 studies over 3 to 8 weeks found no adverse blood or organ values; long-term data and an official maximum level are lacking. In older men, leucine changed neither insulin sensitivity nor blood lipids over 3 months; ammonia levels rose in acute studies only at very high amounts. The German BfR derived its guidance value from animal studies for lack of human data and advises children, adolescents, pregnant and breastfeeding women against isolated BCAAs in relevant amounts.
See all ratings in the ranking (German app)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in a doctor's hands.